Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging

[1]  Dennis C Harrison.  Form and function , 2012, Canadian Medical Association Journal.

[2]  Hiroshi Honda,et al.  Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. , 2010, European journal of radiology.

[3]  M. Mayerhoefer,et al.  Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer. , 2010, European journal of radiology.

[4]  R. Birdwell.  Diffusion-Weighted Magnetic Resonance Imaging of Breast Lesions: First Experiences at 3 T , 2010 .

[5]  Ernst J Rummeny,et al.  Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. , 2009, European journal of radiology.

[6]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[7]  M. Forsting,et al.  Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Bachir Taouli,et al.  Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. , 2009, Radiology.

[9]  H. Oizumi,et al.  Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  Y. Yamashita,et al.  Comparison of diffusion‐weighted MRI and 2‐[fluorine‐18]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography (FDG‐PET) for detecting primary colorectal cancer and regional lymph node metastases , 2009, Journal of magnetic resonance imaging : JMRI.

[11]  U. Sharma,et al.  Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy , 2009, NMR in biomedicine.

[12]  Zhang Yun,et al.  The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinoma , 2009, BMC Cancer.

[13]  N. Blumstein,et al.  Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. , 2008, Radiology.

[14]  K. Kihara,et al.  [Use of diffusion-weighted MRI in monitoring response of lymph node metastatic bladder cancer treated with chemotherary]. , 2008, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[15]  Hiroshi Honda,et al.  Enhanced mass on contrast‐enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast‐enhanced and diffusion‐weighted MR images , 2008, Journal of magnetic resonance imaging : JMRI.

[16]  Roland Bammer,et al.  Magnetic resonance imaging techniques: fMRI, DWI, and PWI. , 2008, Seminars in neurology.

[17]  Joan C Vilanova,et al.  Diffusion-weighted whole-body MR screening. , 2008, European journal of radiology.

[18]  S. Matsumoto,et al.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. , 2008, Radiology.

[19]  E. Hauth,et al.  Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography , 2008, Journal of Nuclear Medicine.

[20]  S. Partridge.  Future Applications and Innovations of Clinical Breast Magnetic Resonance Imaging , 2008, Topics in magnetic resonance imaging : TMRI.

[21]  E. Hauth,et al.  Whole-body PET/CT-mammography for staging breast cancer: initial results. , 2008, The British journal of radiology.

[22]  M. Funke,et al.  Bildgebende Diagnostik des Mammakarzinoms , 2008, Der Radiologe.

[23]  Koji Murakami,et al.  PET/CT supports breast cancer diagnosis and treatment , 2008, Breast cancer.

[24]  S. Shiraishi,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  S. Shiraishi,et al.  Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. , 2008, The Journal of thoracic and cardiovascular surgery.

[26]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[27]  H. Busch,et al.  [Tumor search with diffusion-weighted imaging--first experience]. , 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[28]  Yutaka Imai,et al.  Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.

[29]  Joaquim Barceló,et al.  Resonancia magnética de todo el cuerpo con técnica de difusión (PET virtual) para el cribado de las metástasis óseas , 2007 .

[30]  David A Mankoff,et al.  FDG PET, PET/CT, and breast cancer imaging. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[31]  T. Mochizuki,et al.  Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography , 2007, Radiation Medicine.

[32]  I. Narabayashi,et al.  2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience , 2007, Annals of nuclear medicine.

[33]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[34]  Jianqiao Luo,et al.  [Application of diffusion weighted magnetic resonance imaging to differential diagnosis of breast diseases]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.

[35]  C. Meltzer,et al.  PET/CT: form and function. , 2007, Radiology.

[36]  Katsuyuki Nakanishi,et al.  Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[37]  J. Martí,et al.  [Diffusion-weighted whole-body MRI (virtual PET) in screening for osseous metastases]. , 2007, Radiologia.

[38]  G. Hortobagyi,et al.  Overview of resistance to systemic therapy in patients with breast cancer. , 2007, Advances in experimental medicine and biology.

[39]  I. Sayek,et al.  Re-evaluation of Axillary Skip Metastases in the Era of Sentinel Lymph Node Biopsy in Breast Cancer , 2006, Surgery Today.

[40]  Ora Israel,et al.  The role of FDG‐PET/CT in suspected recurrence of breast cancer , 2006, Cancer.

[41]  N. deSouza,et al.  Diffusion-weighted magnetic resonance imaging and its application to cancer , 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.

[42]  Thierry Metens,et al.  Quantitative diffusion imaging in breast cancer: A clinical prospective study , 2006, Journal of magnetic resonance imaging : JMRI.

[43]  Thomas Beyer,et al.  Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. , 2004, Radiology.

[44]  Thomas Beyer,et al.  Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[45]  Rubens Rd.  7. Management of advanced breast cancer. , 2001 .

[46]  J C Gore,et al.  Diffusion‐weighted imaging in tissues: Theoretical models , 1995, NMR in biomedicine.

[47]  H. Bihl,et al.  Metastases in breast carcinoma , 1994 .

[48]  P A Dekker-de Kiefte,et al.  Diagnosis and Treatment , 2020, Diabetes.

[49]  G. Hal,et al.  Distribution of axillary node metastases bylevel of invasion , 1987 .

[50]  A. Luini,et al.  Distribution of axillary node metastases by level of invasion. An analysis of 539 cases , 1987, Cancer.

[51]  M. Lesser,et al.  Discontinuous or “Skip” Metastases in Breast Carcinomae: Analysis of 1228 Axillary Dissections , 1983, Annals of surgery.